Sarah Lingard
Papers
2
Total Citations
70
H-Index
2
About
Dr. Sarah Lingard is a pioneering stem cell biologist whose work has advanced the scalable production and screening of human neural stem cells for drug discovery and regenerative medicine. Her research centers on developing automated, high-throughput platforms for culturing and chemically modulating human induced pluripotent stem cell (iPSC)-derived neural cells. In her landmark 2012 study (47 citations), she established a fully automated, large-scale culture system and medium-throughput chemical screen to identify modulators of proliferation and viability in iPSC-derived neuroepithelial-like stem cells—a critical step toward reproducible, animal-free models for neurological disease. Earlier, her 2011 paper (23 citations) demonstrated that non-immortalized human neural stem cells could serve as a scalable, physiologically relevant cellular assay platform, circumventing the limitations of immortalized lines. These contributions have provided foundational tools for academic and pharmaceutical labs seeking to test compounds on human-relevant neural cells at scale. Dr. Lingard’s work bridges engineering and biology, enabling more efficient, ethical, and translational approaches to studying neurodevelopment and neurodegeneration. Her achievements underscore the power of automation in democratizing access to complex stem cell models.
Research Focus
Key Achievements
Top Papers
- 1
- 2